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ABSTRACT 
 
 
 
Ferrocene based organometallic compounds have received intense attention in synthetic 
chemistry due to their increasing interest in biological, optical, and electrochemical properties. 
Among them, compounds containing heterocycles linked to ferrocene moiety have 
predominantly attracted importance because of their application in medicinal and materials 
chemistry.  Recently, ferrocene incorporation into several drug compounds have improved the 
activity of the drug showing their potential in the field of medicinal chemistry.  Ferrocene 
substituted tamoxifen and ferrocenyl chloroquine derivatives are among the many examples 
where the compound showed higher activity compared to their organic analogue.  In view of 
their interesting properties and emerging potential, we focused our studies on the synthesis of 
ferrocene based chalcones and study of their biological, electrochemical and sensing properties.  
Chalcones itself constitute an important class of compounds with varied biological activities such 
as anti-cancer, anti-microbials, anti-malarial and anti inflammatory and are prime precursors to 
different types of heterocyclic compounds.  Therefore, we chose to prepare a number of 
ferrocenyl chalcones and understand their electrochemical and biological properties.   
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CHAPTER 1 
INTRODUCTION 
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1.1 Ferrocene  
 
Organometallic chemistry leaped forward in the early 1950s when the structure of 
ferrocene,Fe(C5H5)2  was elucidated.  It was the first of many complexes came to be known as 
metallocene, a name which arose because they precipitated in reactions similar to those of 
aromatic molecules.  Ferrocene has a ferrous ion (Fe2+) coordinated to two cyclopentadienyl (Cp) 
rings. The d-orbitals on Fe2+ are coordinated into the π orbitals on the two cyclopentadienyl radicals to 
form a unique sandwich structure.  It is stable to high temperatures and unaffected by water, strong acids 
and alkalis.  The unique stability of ferrocene is attributed to the distribution of 18 π electrons in the e2g 
and a1g non bonding molecular orbitals (Fig. 1). 
                                 
 
 
 
The carbon-carbon bond distances are 1.40 Å within the five-membered rings, and the 
Fe-C bond distances are 2.04 Å.  Although X-ray crystallography (in the monoclinic space 
group) points to the Cp rings being in a staggered conformation, it has been shown through gas 
Fig 1. 
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phase electron diffraction and computational studies that in the gas phase the Cp rings are 
eclipsed.  The staggered conformation is believed to be most stable in the condensed phase due 
to crystal packing.  The point group of the staggered conformation is D5d and the point group of 
the eclipsed conformation is D5h.Ferrocene behaves like an aromatic compound.  It is susceptible 
to direct electrophilic substitution reactions, giving rise to a variety of substituted ferrocenes. 
 
1.2. Chalcones  
Chalcones (trans-1,3-diaryl-2-propen-1-ones) are natural products belonging to 
flavonoid, are considered as intermediate in the flavonoids biosynthesis, and are widespread in 
plants.  The existence of the α,β-unsaturated ketone moiety in chalcones is a common part found 
in a large number of biological active compounds.  Therefore, chalcone derivatives from nature 
or synthetic origin show diverse pharmacological activities, such as antimicrobial, antitumor, 
anticancer, radical scavenger, and inhibitor of topoisomerase.  Beside, its immense usage in 
medicinal chemistry, it also have potential as artificial sweeteners, novel drugs and 
agrochemicals.  To add to its usefulness, chalcone derivatives have various optical applications 
including second harmonic generation materials in non-linear optics, photorefractive polymers, 
holographic recording materials and fluorescent probes for sensing of metal ions.
1
  Several 
heterocyclic ring compounds like pyrazole, pyrimidines with significant biological activity  are 
synthesis  from chalcones.
2
  When chalcone substitutes the one or both aromatic group of 
ferrrocene and are connected by a enone bridge, gives an important class of compound called 
Ferrocenyl chalcone.  Recent research in organomettalllic chemistry have been focussed on 
synthesis of ferrocenyl chalcones and their derivatives which shows marked electrochemical and 
biological properties.
3,4 
  Due to immense applications of chalcone makes it an important class of 
naturally occurring flavonoids exhibiting a broad spectrum of biological activities such as anti-
cancer, anti-microbial, anti-malarial and anti-inflammatory activities. 
 
 
1.3. Application of ferrocene and its derivatives: 
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Ferrocene itself is nontoxic compound, has good redox property.  It is an anti-aenemic or 
cytotoxic agent.  Ferrocene-containing nucleic acids has been reported to be used in glucose 
biosensors and bioelectronics
5
.  Detail applications of ferrocenyl derivatives are as follows: 
 
1.3.1  MEDICINAL APPLICATIONS OF FERROCENE DERIVATIVES: 
a. Anticancer Activity 
Ferrocenyl derivatives have revolutionized the field of cancer research by being a very potential 
anticancer compound.  Cancer is a class of disease characterized by uncontrolled cell proliferation 
and the ability of these cells to invade other tissues.  It can be treated by methods including 
chemotherapy, which is one of the widely used strategies in the fight of cancer.  Many ferrocenyl 
derivatives show good results as antitumor agents and some of them are now in clinical trials.  
Ferrocifen is more active than tamoxifen
6
 (Fig. 2.) 
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Kenny et al., reported a series of N-(ferrocenylmethyl)benzene-carboxamide derivatives (3) 
which shows cytotoxic effects on the MDA-MB-435-S-F breast cancer cells.
7
(Fig. 3.) 
FIG 2. 
Fig 2. 
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According to Kenny’s and Simenel’s groups  N-(6-ferrocenyl-2-naphthoyl)-g-aminobutyric 
acid ethyl ester (4) and 1-N-ferrocenylmethyl thymine (5) are more active on human lung 
carcinoma cell line H1299 and carcinoma 755 respectively.
8-14
  The anti-cancer activity of 
ferrocenyl derivatives of retinoids toward human lung cancer cell line (A549), human liver 
cancer cell line (BEL7404), and human tongue cancer cell line (Tca) exhibited higher than the 
parent 13-cis-retinoic acid,
15-17
(Fig. 4.) 
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b. Antimalarial activity
 
Chloroquine (7) has long been used in treatment of malaria cause by Plasmodium 
falciparum, P. malariae. Ferrocene derivative of chloroquine, Ferroquine (8) and its derivatives 
(9) are found to be extremely active against CQ-susceptible and CQ-resistant Plasmodium 
falciparum.
18
(Fig. 5.) 
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c. Anti-HIV Agent  
Lately,HIV-1 integrase (IN) has emerged as an important therapeutic target for the design 
of anti-HIV agents because IN catalyzes the insertion of HIV proviral DNA into the host 
genome.  Among the diverse structural classes of IN inhibitors, the β-diketo acid class of 
compounds has shown selective IN inhibition.  For many of these compounds, complexation 
with boron difluoride increases their potency and selectivity towards IN inhibition.  Ferrocenyl 
chalcones, ferrocenyl-2-hydroxy-4-oxo-2-butenoic acid (10) and hydroxyferrocene chalcone (11) 
has shown showed potent strand transfer inhibition.
19
 (Fig. 6) 
 
Fig. 5. 
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1.3.2  FLUORESCENCE PROPERTY:  
Ferrocenyl moiety connected with different fluorescent molecule show interesting 
fluorescence behavior, sometime it acts as auxochrome but some cases it act as quencher.  For 
example in compound Fc-EtCbz (13) it act as auxochrome but in compounds Fc-Naph (14) and  
Fc-Anth (15) ferrocenyl moiety behaves as a fluorescence quencher.
20
 (Fig. 7.) 
Fig. 6. 
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1.3.3  CHEMO SENSOR PROPERTIES: 
There are some reported ferrocene based organometallic compounds which have sensing 
property toward a particular ion.  Lee et al. have reported ferrocenyl chalcones linked with two 
pyrene moieties (16) highly selective toward Fe(III) ions over Fe(II) ions.
21
(Fig. 8.) 
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Recently, Thakur and coworkers
22
 have reported the electrochemical, optical, and cation-
sensing properties of two synthesized triazole-tethered ferrocenyl benzylacetate derivatives (Fig. 
9) which can be used for the selective colorimetric detection of Hg
2+
 in an aqueous environment 
over Ni
+2
and Cu
2+
 cations.   
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Trivedi et. al. have  reported a simple one-pot synthesis, characterization, optoelectronic and 
cation sensing properties of 1-(2-pyridyl)-3-ferrocenylpyrazolines (scheme 1).  These ferrocene 
compounds behave as selective multichannel chemosensors in the presence of Co
2+,
 Cu
2+,
 and 
Zn
2+ 
ions.  A maximum cathodic shift in the redox potential of the ferrocenium couple was 
observed towards the Co
2+ 
ion, while a minimum shift was observed with the Zn
2+
 ion on 
complexation with this receptor.
23 
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Fig 9. 
Scheme 1. 
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1.3.4. FERROCENE DERIVATIVES AS NON LINEAR OPTIC MATERIALS: 
 
Nonlinear optics (NLO) is the branch of optics that describes the behavior light in 
nonlinear media, that is, media in which the dielectric polarization P responds nonlinearly to the 
electric field E of the light.  This nonlinearity is typically only observed at very high light 
intensities (values of the electric field comparable to interatomic electric fields, typically 
10
8
 V/m) such as those provided by lasers.  Above the Schwinger limit, the vacuum itself is 
expected to become nonlinear.  In nonlinear optics, the superposition principle no longer holds. 
Nonlinear optics remained unexplored until the discovery of Second harmonic generation shortly 
after demonstration of the first laser. (Peter Franken et al. at University of Michigan in 1961). 
Second -order NLO materials is used in laser industry and Third-order NLO materials can be 
used for a number of photonic applications, for example, optical signal processing, optical 
communication, optical computing, electro-optic modulation. 
 Ferrocene-containing molecules with nonlinear optical (NLO) properties are currently 
attracting a great deal of attention.  Hou.et.al
24
 have synthesized ferrocenyl ligands [(4-
pyridylamino)-carbonyl]ferrocene(4-PFA) and 1,1-bis[(4-pyridylamino)-carbonyl]ferrocene (4-
BPFA), and their corresponding complexes[Zn(4-PFA)2(NO3)2](H2O) (17), [Hg2(OAc)4(4-
BPFA)2](CH3OH) (18),which are potential third –order NLOs.(Fig. 10.) 
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1.3.5. FERROCENYL AND CHALONE DERIVATIVES AS SOLAR CELL COMPOUND    
There has been considerable research in harnessing solar energy which is a renewable 
and clean source of energy for different applications  such as dye-sensitized solar cells (DSSCs), 
photocatalysis, solar to-chemical conversion, etc., sensitizers with good optical properties over 
the visible range are essential.
25
  A number of molecular sensitizers in the form of organic dyes 
(including heavy metal ion incorporated ones) have been synthesized and are being used, whose  
corresponding methods of synthesis, application and prolonged use are not eco-friendly.  So 
focus has shifted to explore sources of new natural dye systems that are stable, nontoxic 
(biocompatible), and with the desirable optoelectronic properties.
29  
There have been some 
interesting explorations of natural dyes in the context of the dye-sensitized solar cell (DSSC) 
application using pigments obtained from biomaterials such as flowers, fruits and leaves.
26-34  
In 
this regard, Agarkar et al. have studied isobutrin (19) belonging to chalcone class, extracted from 
a natural flower source Butea Monosperma (Flame of the Forest) for possible use in dye 
sensitized solar cells as well as other optoelectronic applications.  In DSSCs, purified isobutrin 
yields very promising solar conversion efficiency of 1.8%. 
35
 (Fig. 11.) 
 
Fig. 10. 
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There are also some ferrocene derivatives those are studied as Dye-sensitized solar cell 
compounds.One of them is reported by Hong et. al  .
36
(Fig. 12.) 
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On the basis of the above literature survey we have been inspired to synthesize multi-
ferrocenyl chalcones and their derivatives.  We have been able to synthesize some multi 
ferrocenyl compounds and their derivatives and characterised using IR and NMR spectroscopic 
techniques.  We will use these compounds for biological, electrochemical and photovoltaic 
study.  The detail description of synthesis and characterisation is given in chapter 2.     
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CHAPTER 2 
SYNTHESIS AND CHARACTERISATION 
OF FERROCENYL CHALCONES 
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2.1. Introduction 
Recent research has been focused on the synthesis and characterizations of carbon chains linked 
with organometallic fragments and study their biological and materialistic properties.  In view of the 
enormous research activity of organometallic compounds containing ferrocenyl and half sandwich 
moieties, we have been motivated to synthesize various compounds containing organic chains and 
multiple metal fragments and understand their biological, electrochemical and optical properties.  
Chalcone, a naturally occurring flavonoides is an antibacterial, anti-inflammatory and anticancer 
pharmacological agent and also have potential application as artificial sweeteners, novel drugs and 
agrochemicals.  In addition, chalcone derivatives are widely used for various optical applications 
including second harmonic generation materials in non-linear optics, photorefractive polymers, 
holographic recording materials and fluorescent probes for sensing of metal ions.  These are also 
widely used to prepare heterocyclic ring compounds like pyrazole, pyrimidines with significant 
biological activity.  Ferrocenyl chalcone compounds belong to a chalcone family in which one or 
both the aromatic group is substituted by ferrocenyl unit and are connected by an enone bridge.  
Recently, a bunch of different ferrocenyl chalcones and their derivatives have been synthesized 
which shows marked electrochemical and biological properties
1
.  These systems have been 
investigated as precursors for a large variety of ferrocene containing heterocycles like pyrazoles, 
pyrimidines etc
2
. It has now been well established that chalcone moieties constitute an important 
class of naturally occurring flavonoids and exhibit a wide spectrum of biological activities such as 
anti-cancer, anti-microbial, anti-malarial and anti-inflammatory activities.  Recent investigation 
reveals their importance in biological studies which led to the immergence of a relatively new field of 
bioorganometallic chemistry 
37
.  A large number of ferrocene and half sandwich based compounds 
have been found to display interesting cytotoxic, DNA cleaving and other biological activities
3,4,38-41
 . 
Ferrocene substituted tamoxifen and ferrocenyl chloroquine derivative are among the many examples 
where ferrocene incorporation have improved the activity of the drug
42
.  Recently, our research group 
have reported some biologically active ferrocenyl and cymantrenyl hydrazone compounds and 
synthesized half-sandwich based dithiocarboxylato-alkyne complexes by sunlight driven reaction.  
Some of these organometallic compounds showed remarkable antibacterial properties
41
.    
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2.2. Experimental Section 
2.2.1   General Procedures 
 All reactions and manipulations were carried out under an inert atmosphere of dry, pre-
purified nitrogen using standard Schlenk line techniques.  Solvents were purified, dried and 
distilled under nitrogen atmosphere prior to use.  Infrared spectra were recorded on a Perkin 
Elmer Spectrum RX-I spectrometer as dichloromethane solutions in 0.1 mm path lengths KBr 
cell and NMR spectra on a 400 MHz Bruker spectrometer in CDCl3.  HPLC grade 
dichloromethane is used for all spectroscopic analysis.  TLC plates (20x20 cm, Silica gel 60 
F254) were purchased from Merck.  The compounds 3a, 3b, 4a and 5a was synthesized and 
characterized according to the procedure established by our research group.  
 
2.2.2. Synthesis of [Fe(η5-C5H4CHO)2] and [Fe(η
 5
-(C5H5)(η
5
-C5H4CHO)]  : 
 
In a two necked round bottom flask, ferrocene (2 gm) (1) was taken with hexane (40ml) 
and was stirred in room temperature under nitrogen atmosphere.  To this reaction mixture, n-
butyl lithium (17ml) was added and left overnight.  Then, DMF(1.8ml) and diethyl ether(8ml) 
was added  and stirred for 1 hour in nitrogen atmosphere.Then,35% HCl(4ml) was taken in H2O 
(27ml) and added to the reaction mixture and stirred for some time and then removed.  The 
reaction was monitored by TLC.  On completion of the reaction, the solution was dried under 
vacuum and the residue was dissolved in dichloromethane solvent and subjected to 
chromatographic work- up using preparative TLC.  Pure dialdehyde and monoaldehyde 
ferrocene was separated through column chromatography. 
 
2.2.3. Synthesis of Fe(η5-C5H4COCH3)2]  :                                                 
In a two necked round bottom flask, ferrocene (4 gm) (2) was taken with DCM (50ml) 
and stirred in room temperature under nitrogen atmosphere for 10 minutes to dissolve.  Then, 
acetyl chloride (4ml) was added slowly and left for stirring for 15 minutes.  After that, AlCl3 
(9.2gm) was added slowly and left for stirring for 4 hours.  The reaction was monitored by TLC.  
Then, reaction mixture was poured in a beaker with ice cold water and extracted.  On completion 
23 
 
of the reaction, the solution was dried under vacuum and the residue was subjected to 
chromatographic work using preparative TLC.  Pure diacetyl and monoacetyl ferrocene was 
separated through column chromatography. 
 
2.2.4. Synthesis Of [(η5-C5H5)Fe(η
5
-C5H4)C(O)CHCH(η
5
-C5H4)Fe(η
5
-
C5H4)CHO] : 
A two necked round bottomed flask containing a ethanolic solution (10 ml) of [Fe(5-
C5H4CHO)2] (1a) (21mg, 0.1 mmol) and [(
5
C5H5)Fe(
5
-C5H4COCH3)](2b)  (0.1 mmol) was 
taken under inert atmosphere.  Sodium hydroxide in ethanol solution was then added in excess to 
the reaction mixture and stirring was continued at room temperature under inert atmosphere for 
one hour and then subjected to vacuum for 30 minutes.  The reaction was continuously 
monitored by TLC and on completion of the reaction the solution was dried under vacuum and 
the residue was dissolved in dichloromethane solvent and subjected to chromatographic work-up 
using column chromatography.  The products were separated using ethylacetate/hexane (20:70 
v/v) solvent mixture. (Scheme 3)  
 
3a. IR(CO, cm
-1
,CH2Cl2) 1683(vs), 1647 (vs), 1588(s). 
1
H NMR (, CDCl3): 4.25 (s, η
5
-C5H5, 
5H), 4.56 (t, η5-C5H4, 2H), 4.61 (t, η
5
-C5H4, 2H), 4.62 (t, η
5
-C5H4, 2H), 4.68 (t, η
5
-C5H4, 2H), 
4.79 (m, η5-C5H4, 4H), 4.91 (t, η
5
-C5H4, 2H), 6.77 (d, ═CH, J = 15, 1H), 7.59 (d, CH═, J = 15, 
1H), 9.95 (s, CHO, 1H).   
3b. IR(CO, cm
-1
,CH2Cl2) 1647 (vs), 1589(s)
1
H NMR (, CDCl3): 4.2(s, η
5
-C5H5, 5H), 4.49 (t, 
η5-C5H4, 4H), 4.54 (t, η
5
-C5H4, 4H), 4.57 (t, η
5
-C5H4, 4H), 4.01 (t, η
5
-C5H4, 4H),  
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2.2.5. Reaction of [(η5-C5H5)Fe(η
5
-C5H4)C(O)CHCH(η
5
-C5H4)Fe(η
5
-
C5H4)CHO] with O-hydroxy acetophenone  
Room temperature reaction was carried out with [(η5-C5H5)Fe(η
 5
-C5H4)C(O)CHCH(η
5
-
C5H4)Fe(η
 5
-C5H4)CHO] (3a) and o-hydroxy acetophenone (4) in ethanol solvent and in presence 
of excess ethanol.  The reaction was stirred at nitrogen atmosphere for 16 hours and subjected to 
vacuum for 30 minutes.  Reaction was continuously monitored using TLC.  The product was 
isolated by preparative TLC using ethylacetate/pet.Ether solvent mixture. Preliminary 
observation of the product polarity (that is the solvent front at which it moves in TLC) reveals 
the tentative formation of the desired compound as shown in Scheme 4.  Compound (4a)  
confirmation was  done by IR and NMR spectroscopy. 
4a. IR(CO, cm
-1
,CH2Cl2) 1731(vs), 1632(vs), 1579(s)1564(s),3440(br) ,
1
H NMR (, CDCl3): 
4.179 (s, η5-C5H5, 5H), 4.5 (m, η
5
-C5H4, 4H), 4.56(t, η
5
-C5H4, 2H), 4.6 (m, η
5
-C5H4, 4H), 4.75 (t, 
η5-C5H4, 2H), 7.8 (d, ═CH, J = 15.6, 1H), 6.65 (d, CH═, J = 15.6, 1H), 7.6 (d, ═CH, J = 15.2, 
1H), 7.18 (d, CH═, J = 16, 1H) 13.00 (s, OH, 1H).   
 
2.2.6.   Reaction of [(η5-C5H5)Fe(η
5
-C5H4)C(O)CHCH(η
5
-C5H4)Fe(η
5
-
C5H4)CHO] with Acetone: 
Room temperature reaction was carried out with [(η5-C5H5)Fe(η
 5
-C5H4)C(O)CHCH(η
5
-
C5H4)Fe(η
5
-C5H4)CHO] (3a) and acetone (5) in ethanol solvent and in presence of excess 
ethanol.  The reaction was refluxed at nitrogen atmosphere for 45 minutes and then vacuum to 
dry.  Reaction was continuously monitored using TLC.  The product was isolated by preparative 
TLC using ethylacetate/Pet.Ether solvent mixture.  Preliminary observation of the product 
polarity (that is the solvent front at which it moves in TLC) reveals the tentative formation of the 
desired compound as shown in Scheme 5.  The structural identity of compound 5a confirmation 
was done by IR and NMR spectroscopy. 
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5a: IR (CO, cm
-1
, CH2Cl2) 1660(vs), 1650(vs), 1614(s), 1589(s).
 1
H NMR (, CDCl3): 5.319 (s, 
η5-C5H5, 5H), 4.877 (t, η
5
-C5H4, 2H), 4.599(t, η
5
-C5H4, 2H), 4.573 (t, η
5
-C5H4, 2H), 4.513 (t, η
5
-
C5H4, 2H), 4.465 (t, η
5
-C5H4, 2H), 7.562 (d, ═CH, J = 15.6, 1H), 6.677 (d, CH═, J = 15.6, 1H), 
7.29 (d, ═CH, 1H), 6.3 (d, CH═,1H), 2.233 (s, CH3, 3H). 
 
2.3.  Results and discussion 
All the starting materials Mono-aldehyde ferrocene (1b), Di-aldehyde ferrocene (1a), 
Mono-acetyl ferrocene (2a) and Di-acetyl ferrocene (2b) are synthesized using reported 
procedure and are confirmed from previous prepared compounds. 
Fe
n-BuLi
TMEDA
DMF
HCl
O
H
Fe O
H
SCHEME 1.
+ Fe
O
H
1 1a
1b
 
O
CH3
FeFe O
CH3
AlCl3
CH3COCl
+
O
CH3
Fe
SCHEME 2
2 2a 2b
 
 
Synthesis of ferrocenyl chalcone derivatives 3a, 3b, 4a, 5a, was carried out by modified 
Claisen-Schmidt condensation.  Compound [(η5-C5H5)Fe(η
5
-C5H4)C(O)CHCH(η
5
-C5H4)Fe(η
5
-
C5H4)CHO], 3a,and ,[Fe2(η
5
-C5H4)4{(CHCH)C(O)}2], 3b, (scheme-3) were synthesized using 
sodium hydroxide in ethanol, 1 hour stirring and 5 min vaccum dry. required.  The reaction times 
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were determined by monitoring the consumption of starting materials as indicated by TLC.  The 
reaction time for the conventionally synthesized chalcones is more than 10 to 12 h, with very 
small yield while in modified procedure where vacuum is used it gives excellent yield within 5 to 
10 minutes.  The separation of 3a and 3b is difficult from the reaction mixture and yield of 3a is 
less in this method, so a new procedure with red-mud (solid state synthesis, stirring at 65
0
C for 7 
hours) is employed to synthesize 3a which gives excellent yield (scheme-4).  The formation of 
3a is confirmed by IR and NMR in DCM and CDCl3 where 1680 cm
-1
 and 1650 cm
-1
 are 
aldehyde C=O and α,β-C=O respectively in IR spectrum and , 4.25 (s, η5-C5H5, 5H), 4.56 (t, η
5
-
C5H4, 2H), 4.61 (t, η
5
-C5H4, 2H), 4.62 (t, η
5
-C5H4, 2H), 4.68 (t, η
5
-C5H4, 2H), 4.79 (m, η
5
-C5H4, 
4H), 4.91 (t, η5-C5H4, 2H), 6.77 (d, ═CH, J = 15, 1H), 7.59 (d, CH═, J = 15, 1H), 9.95 (s, CHO, 
1H) shows the di-ferrocenyl compound with a pendent aldehyde group.  The 3b compound is 
symmetrical and therefore 1644 cm
-1
 shows the presence of two α,β-C=O groups and , 4.2 (s, 
η5-C5H5, 5H), 4.49 (t, η
5
-C5H4, 4H), 4.54 (t, η
5
-C5H4, 4H), 4.57 (t, η
5
-C5H4, 4H), 4.01 (t, η
5
-
C5H4, 4H), shows the tri ferrocenyl symmetrical chalcone. 
CH3
Fe
O
H
O
H
Fe
NaOH
O
Fe Fe+ +
Fe Fe
H
O
Fe
RT, Vac
O
O
O
SCHEME 3
3a 3b1a2b
 
                      
CH3
Fe
O
H
O
H
Fe
Red mud
O
Fe Fe+
H
O
65oC
O
SCHEME 4
3a1a2b
 
 Compound 4a was synthesized from 3a and 4 using sodium hydroxide in ethanol and 1 
hour stirring and 15 min vacuum dry (scheme-5) .  The reaction times were determined by 
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monitoring the consumption of starting materials as indicated by TLC.  The product was 
separated using preparative thin layer chromatography with pet ether and ethyl acetate as solvent 
mixture.  In IR 1731 cm
-1
, 1632 cm
-1
, 3440 cm
-1
 shows the presence of two carbonyl groups and 
the presence of –OH group respectively.  In NMR , 4.179 (s, η5-C5H5, 5H), 4.5 (m, η
5
-C5H4, 
4H), 4.56(t, η5-C5H4, 2H), 4.6 (m, η
5
-C5H4, 4H), 4.75 (t, η
5
-C5H4, 2H) indicates the presence of 
ferrocenyl cp rings while 7.8 (d, ═CH, J = 15.6, 1H), 6.65 (d, CH═, J = 15.6, 1H), 7.6 (d, ═CH, J 
= 15.2, 1H) and 7.18 (d, CH═, J = 16, 1H) reveals the presence of olefinic protons and peaks at 
13.00 (s, OH, 1H) shows the presence of OH protons.  The IR and NMR spectral analysis reveals 
the formation of unsymmetrical di ferrocenyl chalcone (3a).  
O
H
O
Fe Fe
OH O
NaOH
O
O
OH
Fe Fe+
1h stirring,
15 min dry vaccum
SCHEME 5
3a 4
4a
 
 Compound 5a was synthesized from 3a and 4 using sodium hydroxide in ethanol 
(scheme-6).  The duration of the reaction was determined by monitoring the consumption of 
starting materials as indicated by TLC.  The product was separated using preparative thin layer 
chromatography with pet ether and ethyl acetate solvent mixture.  In IR spectrum shows bands at 
1660 cm
-1
 and 1650 cm
-1
 region and indicates the presence of two carbonyl groups in the 
molecules.  
1
H NMR shows ferrocenyl peaks at ,5.32 (s, η5-C5H5, 5H), 4.88 (t, η
5
-C5H4, 2H), 
4.6 (t, η5-C5H4, 2H), 4.57 (t, η
5
-C5H4, 2H), 4.51 (t, η
5
-C5H4, 2H), 4.47 (t, η
5
-C5H4, 2H) and peaks 
at 7.562 (d, ═CH, J = 15.6, 1H), 6.677 (d, CH═, J = 15.6, 1H), 7.29 (d, ═CH, 1H), 6.3 (d, 
CH═,1H) shows the presence of olefinic protons while methyl protons have been detected at 
2.23 (s, CH3, 3H) position.  Spectroscopic analysis reveals the presence of unsymmetrically 
substituted ferrocenyl-chalcone with a pendent acetyl group. 
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O
H
O
Fe Fe
NaOH
O
O
Fe Fe+
45 min reflux
O
SCHEME 6
3a 5 5a
 
2.4.  Conclusion: 
Multi-ferrocenyl chalcones with more than one ferrocene groups have been synthesized 
using condensation reaction and characterised by IR and NMR spectroscopy.  The biological and 
electrochemical studies of the synthesized organometallic compounds are under investigation. 
Selective synthesis of ferrocenyl chalcones with pendant aldehyde and ketonic group have been 
carried out using redmud and has been used to prepare unsymmetrically substituted ferrocenyl 
compounds. These compounds can also be used to link different heterocyclic moieties and 
flouroscent units to get organometallic compounds with novel properties. 
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SC-Fc2Mono(CHO)Chalcone
Name
Sample 013 Fc2Mono(CHO)Chalcone By NIT-SC Date Friday, November 21 2014
Description
4000 4003500 3000 2500 2000 1500 1000 500
110
90
92
94
96
98
100
102
104
106
108
cm-1
%
T
[(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4)CHO]
1680.4cm-1<c=o>
1650.6cm -1<c=o>
1588cm-1<c=c>
1451.1
1373.7
1352.9
1290.3
1245.7
1105.7
1079
1031.3
1001.5
974.69
909.18
825.8
745.4
504.22
SC-Fc2Mono(CHO)di chal (2)
Name
Sample 014 Fc2Mono(CHO)Di chal By NIT-SC Date Friday, November 21 2014
Description
4000 4003500 3000 2500 2000 1500 1000 500
111
99
99
100
101
102
103
104
105
106
107
108
109
110
cm-1
%
T 1731
1644.7cm-1<c=o> 1588cm-1<c=c>
1448.1
1376.7
1355.8
1275.4
1248.6
1177.2
1079
971.71
825.8
748.39
501.24
4. ANNEXURE 1: 
a)IR OF [(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4)CHO]:    
                                                                                                                                  O
H
O
Fe Fe
    
                                                                                                                                       
                                                                                                                                                                   
 
 
 
 
 
 
 
b) IR OF [Fe2(
5
-C5H4)4{(CHCH)C(O)}2]:    
                                                                                                                                               
O
Fe
Fe
O
Fe
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SC-Fc2chalphOH (1)
Name
Sample 010  O-hydroxy aceto phenone Fc2Mono(CHO) chalcone By NIT-SC Date Friday, November 21 2014
Description
4000 4003500 3000 2500 2000 1500 1000 500
110
95
96
98
100
102
104
106
108
cm-1
%
T
[(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4) C(O)CHCH(ArOH)]
2957.8
2919.1
2850.6
1731cm-1<c=o>
1632.8cm-1<c=o>
1579.2cm-1<c=c>
1564.3cm-1<c=c>
1486.8
1463
1448.1
1305.2
1272.5
1245.7
1207
1156.3
1076
1025.3
968.73
909.18
819.85
763.28
751.36
3440.2cm-1<oh>
SC-Acetyl Fc2di chal (1)
Name
Sample 015 Acetyl Fc2 Di chal By NIT-SC Date Friday, November 21 2014
Description
4000 4003500 3000 2500 2000 1500 1000 500
108
93
94
96
98
100
102
104
106
108
cm-1
%
T
[(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4) C(O)CHCH(CH3)]
1650.6cm-1<c=o>
1614.9cm-1<c=c>
1660.6cm-1<c=o>
1589.9cm-1<c=c>
2960.8
2922
2850.6
1728
1448.1
1355.8
1257.6
1183.1
1079
968.73
909.18
822.83
763.28
751.36
c) IR OF [(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4) 
C(O)CHCH(ArOH)]: 
 
                                                                                                                                                  
O
O
OH
Fe Fe
 
 
 
 
 
 
 
 
d)IR OF [(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4) 
C(O)CHCH(CH3)]: 
                                                                                                                                                   
O
O
Fe Fe
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ANNEXURE 2: 
 
a)NMR OF [(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-
C5H4)CHO]: 
                                                                                                         
Fe Fe
O
H
O
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b) NMR OF [Fe2(
5
-C5H4)4{(CHCH)C(O)}2]:    
                                                                                                               
O
Fe
Fe
O
Fe
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c)IR OF [(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4) 
C(O)CHCH(ArOH)]: 
                                                                                 
O
O
OH
Fe Fe
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d)NMR OF [(η5-C5H5)Fe(η 5-C5H4)C(O)CHCH(η5-C5H4)Fe(η 5-C5H4) 
C(O)CHCH(CH3)]: 
                                                                                                   
O
O
Fe Fe
                               
